Adeline L. Vanderver, MD

Dr. Adeline Vanderver is an attending physician in the Division of Neurology at Children’s Hospital of Philadelphia (CHOP) and the Jacob A. Kamens Endowed Chair in Neurologic Disorders and Translational Neurotherapeutics. She is also Program Director of the Leukodystrophy Center of Excellence at CHOP.

Dr. Vanderver graduated with a degree in medicine from Universite Catholique de Louvain in Brussels, Belgium. She completed her residency in pediatrics at Nemours/A.I. duPont Hospital for Children in Wilmington, DE, and Thomas Jefferson University in Philadelphia, PA. She then pursued a child neurology fellowship at Children's National Medical Center in Washington, DC, and a fellowship in biochemical genetics at the National Human Genome Research Institute/National Institutes of Health in Bethesda, MD.

Dr. Vanderver’s has helped clarify the molecular etiology over a dozen leukodystrophies and has contributed more than 100 peer reviewed manuscripts to the literature on leukodystrophies over the past decade. She has contributed to the development of new standards of care for children with leukodystrophies by advancing leukodystrophy gene discovery, creating new therapies, and supporting and advocating for patients and their families.

In addition to providing scientific and administrative direction to the Global Leukodystrophy Initiative Clinical Trials Network, she will direct Project 4 and will serve as a co-investigator on Project 1 and Project 3.